The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy analysis of a phase III study of androgen deprivation therapy (ADT) +/- docetaxel (D) for men with biochemical relapse (BCR) after prostatectomy.
 
Michael J. Morris
Consulting or Advisory Role - Astellas Pharma; Bayer; Millennium; Progenics
Research Funding - Agensys (Inst); Bayer (Inst); Janssen Oncology (Inst); Sanofi (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - fujifilm
 
Patrick Hilden
No Relationships to Disclose
 
Martin Edwin Gleave
Stock and Other Ownership Interests - Oncogenex
Honoraria - Amgen; Astellas Pharma; Janssen
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Janssen; Oncogenex
Speakers' Bureau - Astellas Pharma; Janssen
Research Funding - Oncogenex
Travel, Accommodations, Expenses - Amgen; Janssen
 
Andrew J. Armstrong
Honoraria - Dendreon; Sanofi
Consulting or Advisory Role - Bayer; Dendreon; Janssen Biotech; Medivation; Novartis; Sanofi
Speakers' Bureau - Dendreon
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); ImClone Systems (Inst); Janssen Oncology (Inst); KangLaiTe (Inst); Medivation (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Circulating tumor cell novel capture technology (Inst)
Travel, Accommodations, Expenses - Dendreon; Janssen Biotech; Medivation
 
Michael Anthony Carducci
Honoraria - Sanofi
Consulting or Advisory Role - Amgen; Astellas Pharma; Medivation
Research Funding - Amgen (Inst)
 
Fred Saad
Honoraria - Abbvie; Amgen; Astellas Pharma; Bayer; Janssen Oncology; Novartis; Sanofi
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; Bavarian Nordic; Janssen Oncology; Millennium; Novartis; Sanofi
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Oncogenex (Inst); Sanofi (Inst)
 
Erica Simone Dayan
No Relationships to Disclose
 
Julie Filipenko
Consulting or Advisory Role - BrainScope; Neurometric Evaluation Services NY
Patents, Royalties, Other Intellectual Property - BrainScope
 
Ilyse Acosta
No Relationships to Disclose
 
Glenn Heller
Consulting or Advisory Role - Millennium
 
Howard I. Scher
Honoraria - Chugai Pharma
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Celgene; Endo Pharmaceuticals; Endocyte; Exelixis; Ferring; Foundation Medicine; Genentech; Janssen; Medivation; OncologySTAT; Palmetto GBA; Pfizer; Sanofi; Takeda; Ventana Medical Systems; WIRB-Copernicus Group
Speakers' Bureau - WebMD
Research Funding - BIND Biosciences (Inst); Exelixis (Inst); Janssen (Inst); Janssen Diagnostics (Inst); Medivation (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Celgene; Endocyte; Exelixis; Ferring; Genentech; Janssen; Pfizer; Sanofi; Takeda; WIRB-Copernicus Group